Home › Asset managers › Gabelli › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Gabelli voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
483 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Gabelli voted | Funds |
|---|---|---|---|---|---|---|---|
| THE WILLIAMS COMPANIES, INC. | April 28, 2026 | Election of Director for a One-Year Term: VACANT | Director Elections | Board | ABSTAIN | 2 | |
| THERAPEUTICSMD, INC. | December 15, 2025 | To approve an amendment to our Amended and Restated Articles of Incorporation, as amended, to increase the number of authorized shares of common stock, $0.001 par value per share, to 640,000,000 shares; | Capital Structure | Board | AGAINST | 2 | |
| TYSON FOODS, INC. | February 5, 2026 | To approve the amendment and restatement of the Tyson Foods, Inc. 2000 Stock Incentive Plan, a copy of which is attached to the Proxy Statement as Exhibit A. | Compensation | Board | ABSTAIN | 2 | |
| U-HAUL HOLDING COMPANY | August 21, 2025 | The approval of the U-Haul Holding Company 2025 Stock Option Plan (Shelf Stock Option Plan). | Compensation | Board | AGAINST | 2 | |
| UNITED NATURAL FOODS, INC. | December 16, 2025 | The approval of the Fifth Amended and Restated 2020 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 2 | |
| VIEMED HEALTHCARE, INC. | June 4, 2026 | Amendments to Security Based Compensation Plan - To consider and, if thought appropriate, to pass an ordinary resolution (the text of which is disclosed in Section 10(iv) of the Management Information and Proxy Circular) to ratify, confirm, and approve the Second Amendment to 2024 Omnibus Plan Resolution, as more particularly described in the Management Information and Proxy Circular. | Compensation | Board | ABSTAIN | 2 | |
| VISTANCE NETWORKS, INC. | May 7, 2026 | Approval of additional shares under the Company's 2019 Long- Term Incentive Plan. | Compensation | Board | ABSTAIN | 2 | |
| WILLAMETTE VALLEY VINEYARDS, INC. | July 12, 2025 | Approval of the Company's 2025 Omnibus Equity Incentive Plan. | Compensation | Board | AGAINST | 2 | |
| WINNEBAGO INDUSTRIES, INC. | December 16, 2025 | Approve our amended and restated 2019 Omnibus Incentive Plan | Compensation | Board | AGAINST | 2 | |
| YEXT, INC. | June 10, 2026 | Approve the amended, restated and extended Yext, Inc. 2016 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 2 | |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | June 17, 2026 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| ADVANCED MICRO DEVICES, INC. | May 13, 2026 | Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the current fiscal year. | Audit-related | Board | AGAINST | 1 | |
| ALPHABET INC. | June 5, 2026 | Ratification of appointment of Ernst & Young LLP as Alphabet's independent registered public accounting firm for the fiscal year ending December 31, 2026 | Audit-related | Board | AGAINST | 1 | |
| ANGI INC. | June 10, 2026 | Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| ANHEUSER-BUSCH INBEV SA | April 29, 2026 | Remuneration report: Proposed resolution: approving the remuneration report for the financial year 2025. | Say-on-Pay | Board | ABSTAIN | 1 | |
| ARROWHEAD PHARMACEUTICALS, INC. | March 19, 2026 | Approval of the Arrowhead Pharmaceuticals, Inc. Amended and Restated 2021 Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| ASTRAZENECA PLC | April 9, 2026 | TO AUTHORISE THE DIRECTORS TO DISAPPLY PRE- EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| ASTRAZENECA PLC | April 9, 2026 | To authorize the Directors to disapply pre-emption rights1 | Capital Structure | Board | ABSTAIN | 1 | |
| ATLANTIC UNION BANKSHARES CORPORATION | May 5, 2026 | To approve the compensation of our named executive officers (an advisory, non-binding ''Say on Pay'' resolution) | Say-on-Pay | Board | AGAINST | 1 | |
| ATRICURE, INC. | May 18, 2026 | Proposal to approve an amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000. | Compensation | Board | ABSTAIN | 1 | |
| BARCLAYS PLC | May 7, 2026 | TO AUTHORISE THE DIRECTORS TO ALLOT EQUITY SECURITIES FOR CASH AND OR SELL TREASURY SHARES OTHER THAN ON PRO RATA BASIS TO SHAREHOLDERS OF NO MORE THAN 5 PER CENT OF ISC | Capital Structure | Board | ABSTAIN | 1 | |
| BEIJING ENTERPRISES WATER GROUP LTD | April 22, 2026 | (A) TO APPROVE, CONFIRM AND RATIFY THE 2026 DEPOSIT SERVICES MASTER AGREEMENT AND THE TRANSACTIONS CONTEMPLATED THEREUNDER; (B) TO APPROVE AND CONFIRM THE PROPOSED ANNUAL CAPS; AND (C) TO AUTHORIZED THE DIRECTORS, ACTING TOGETHER, INDIVIDUALLY OR BY COMMITTEE, TO TAKE SUCH ACTIONS, DO ALL SUCH ACTS AND THINGS AND EXECUTE ALL SUCH FURTHER DOCUMENTS OR DEEDS AS THEY MAY CONSIDER NECESSARY, APPROPRIATE, DESIRABLE OR EXPEDIENT FOR IMPLEMENTATION OF OR GIVING EFFECT TO THE 2026 DEPOSIT SERVICES MASTER AGREEMENT, THE PROPOSED ANNUAL CAPS AND ANY OF THE TRANSACTIONS CONTEMPLATED THEREUNDER | Extraordinary Transactions | Board | ABSTAIN | 1 | |
| BEIJING ENTERPRISES WATER GROUP LTD | May 27, 2026 | TO EXTEND THE GENERAL MANDATE TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE OR OTHERWISE DEAL WITH ADDITIONAL SHARES OF THE COMPANY BY THE AMOUNT OF SHARES PURCHASED | Capital Structure | Board | AGAINST | 1 | |
| BEIJING ENTERPRISES WATER GROUP LTD | May 27, 2026 | TO GRANT A GENERAL MANDATE TO THE DIRECTORS OF THE COMPANY TO ALLOT, ISSUE OR OTHERWISE DEAL WITH ADDITIONAL SHARES OF THE COMPANY | Capital Structure | Board | AGAINST | 1 | |
| BIGLARI HOLDINGS INC. | April 8, 2026 | Election of Director: 1. Sardar Biglari | Director Elections | Board | WITHHOLD | 1 | |
| BIGLARI HOLDINGS INC. | April 8, 2026 | Election of Director: 2. Philip L. Cooley | Director Elections | Board | WITHHOLD | 1 | |
| BIGLARI HOLDINGS INC. | April 8, 2026 | Election of Director: 3. Kenneth R. Cooper | Director Elections | Board | WITHHOLD | 1 | |
| BIGLARI HOLDINGS INC. | April 8, 2026 | Election of Director: 4. John G. Cardwell | Director Elections | Board | WITHHOLD | 1 | |
| BIGLARI HOLDINGS INC. | April 8, 2026 | Election of Director: 5. Ruth J. Person | Director Elections | Board | WITHHOLD | 1 | |
| BRIDGEPOINT GROUP PLC | May 12, 2026 | TO AUTHORISE THE DIRECTORS TO DISAPPLY PRE- EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| BROADCOM INC | April 20, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Broadcom for the fiscal year ending November 1, 2026. | Audit-related | Board | AGAINST | 1 | |
| CATERPILLAR INC. | June 10, 2026 | Ratification of our Independent Registered Public Accounting Firm | Audit-related | Board | AGAINST | 1 | |
| CELCUITY INC. | May 14, 2026 | To approve the Celcuity Inc. 2026 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| CELCUITY INC. | May 14, 2026 | To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan. | Capital Structure | Board | ABSTAIN | 1 | |
| CHUBB LIMITED | May 21, 2026 | Election of Auditors - Ratification of appointment of PricewaterhouseCoopers LLP (United States) as independent registered public accounting firm for purposes of U.S. securities law reporting | Audit-related | Board | AGAINST | 1 | |
| CISCO SYSTEMS, INC. | December 16, 2025 | Ratification of PricewaterhouseCoopers LLP as Cisco's independent registered public accounting firm for fiscal 2026. | Audit-related | Board | AGAINST | 1 | |
| COMPANHIA DE SANEAMENTO BASICO DO ESTADO | April 28, 2026 | Amend the third paragraph of Article 3 of the Bylaws to update the value of the authorized capital by adding 21,396,937 shares, as per the Management Proposal. | Capital Structure | Board | ABSTAIN | 1 | |
| CSL LTD | October 28, 2025 | ADOPTION OF THE REMUNERATION REPORT | Say-on-Pay | Board | AGAINST | 1 | |
| CYTOMX THERAPEUTICS, INC. | June 17, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan; | Compensation | Board | AGAINST | 1 | |
| DANAHER CORPORATION | May 5, 2026 | To approve the Company's Amended and Restated Omnibus Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| DATANG INTERNATIONAL POWER GENERATION CO LTD | December 30, 2025 | TO CONSIDER AND APPROVE THE RESOLUTION ON THE FINANCING PROPOSAL OF DATANG POWER AS THE PARENT COMPANY FOR THE YEAR 2026 | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer | Say-on-Pay | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Allocation of income for the year ended December 31, 2025 | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Allocation of the accumulated deficit to the ''Additional paid-in capital'' | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the compensation policy for the Chairman of the Board of Directors for the year ending December 31, 2026 | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the compensation policy for the Chief Executive Officer and Deputy Chief Executive Officer for the year ending December 31, 2026 | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the compensation policy for the Directors for the year ending December 31, 2026 | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the fixed, variable and non-recurring components of overall compensation and benefits of all types paid or assigned during the year ended December 31, 2025, to Mr. Michel de Rosen, Chairman of the Board of Directors | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the fixed, variable and non-recurring components ofoverall compensation and benefits of all types paid or assignedduring the year ended December 31, 2025, to Mr. Daniel Tasse,Chief Executive Officer | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Approval of the information set out in section I of Article L.22-10-9 of the French Commercial Code on the compensation of corporate officers for the year ended December 31, 2025 | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Authorization to be granted to the Board of Directors to allocate for free existing and/or to be issued shares to employees and/or certain corporate officers of the Company or related companies or economic interest groups | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Authorization to be granted to the Board of Directors to buy back company shares on the Company's behalf pursuant to Article L.22- 10-62 of the French Commercial Code | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Authorization to be granted to the Board of Directors to grant stock options to employees and/or certain officers of the Company or related companies or economic interest groups | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of authority to be granted to the Board of Directors to decide on any merger-absorption, spin-off or partial contribution of assets | Extraordinary Transactions | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of authority to be granted to the Board of Directors to decide on the issue of ordinary shares to be issued immediately or in the future by the Company, without preferential subscription rights in favor of a category of persons satisfying determined characteristics within the framework of an equity financing agreement on the United States stock market known as ''At-The- Market'' or ''ATM Program'' | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of authority to be granted to the Board of Directors to increase the number of securities to be issued in the event of a capital increase with or without preferential subscription rights, in the event of excess demand | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of authority to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares with preferential subscription rights | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of authority to be granted to the Board of Directors to issue warrants (BSA), subscription and/or acquisition of new and/or existing warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable warrants (BSAAR) without preferential subscription rights in favor of a category of persons | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation of powers to be granted to the Board of Directors to issue ordinary shares and/or equity securities giving access to other equity securities or to the allocation of debt securities and/or securities giving access to ordinary shares, without preferential subscription rights in favor of one or more persons specifically designated by the Board of Directors | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation to be granted to the Board of Directors to increase the share capital by issuance of ordinary shares and/or securities giving access to the share capital within the limits set by the applicable legal and regulatory provisions on the date of the capital increase in consideration for contributions in kind of securities or securities giving access to the share capital | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Delegation to be granted to the Board of Directors to reduce the share capital by cancellation of shares pursuant to Article L.22-10- 62 of the French Commercial Code | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Increase of the total remuneration (annual budget) allocated to Directors | Compensation | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Overall limit on the maximum authorized amounts set under the resolutions thirty-fifth and thirty-sixth | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Overall limit on the maximum authorized amounts set under the resolutions twenty-second, twenty-third, twenty-fourth, twenty-fifth, twenty-sixth, twenty-eighth and thirtieth resolutions | Capital Structure | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Please refer below and to the other side of the card for a description of the matters submitted at the Annual General Meeting. | Director Elections | Board | ABSTAIN | 1 | |
| DBV TECHNOLOGIES S.A. | June 3, 2026 | Renewal of the term of office of KPMG, as statutory auditor | Audit-related | Board | ABSTAIN | 1 | |
| DENTSPLY SIRONA INC. | June 2, 2026 | Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. | Compensation | Board | AGAINST | 1 | |
| DIAGEO PLC | November 6, 2025 | DISAPPLICATION OF PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| EATON CORPORATION PLC | April 22, 2026 | Approving the appointment of Ernst & Young LLP as Independent auditor for 2026 and authorizing the Audit Committee of the Board of Directors to set auditor remuneration. | Audit-related | Board | AGAINST | 1 | |
| ELI LILLY AND COMPANY | May 4, 2026 | Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. | Audit-related | Board | AGAINST | 1 | |
| EMERA INC | May 21, 2026 | AMEND STOCK OPTION PLAN | Compensation | Board | ABSTAIN | 1 | |
| EMERGENT BIOSOLUTIONS INC. | April 29, 2026 | To approve an amendment to the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. | Compensation | Board | ABSTAIN | 1 | |
| ENGIE | April 29, 2026 | Delegation of authority to the Board of Directors to increase the number of shares to be issued in the event of a capital increase. with or without preferential subscription rights for shareholders. | Capital Structure | Board | ABSTAIN | 1 | |
| ENI S.P.A | May 6, 2026 | Appointment of the Director: Slate proposed by the Shareholder Italian Ministry of the Economy and Finance. | Director Elections | Board | ABSTAIN | 1 | |
| ENI S.P.A | May 6, 2026 | Appointment of the Director: Slate proposed by the Shareholder Romano Minozzi and his subsidiaries. | Director Elections | Board | ABSTAIN | 1 | |
| ENI S.P.A | May 6, 2026 | Appointment of the Statutory Auditors: Slate proposed by a group of Shareholders composed of asset management companies and other Institutional Investors | Audit-related | Board | ABSTAIN | 1 | |
| ENI S.P.A | May 6, 2026 | Long term incentive Plan 2026-2028 and disposal of Eni treasury shares to serve the Plan. | Compensation | Board | ABSTAIN | 1 | |
| FEDEX CORPORATION | September 29, 2025 | Ratify the appointment of Ernst & Young LLP as FedEx's independent registered public accounting firm for fiscal year 2026. | Audit-related | Board | AGAINST | 1 | |
| FEVERTREE DRINKS PLC | June 9, 2026 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| FIRST MAJESTIC SILVER CORP. | June 10, 2026 | Say on Pay Advisory Vote BE IT RESOLVED as an ordinary resolution, on an advisory basis and not to diminish the role and responsibilities of the board of directors, that the shareholders accept the approach to executive compensation disclosed in the Company's Information Circular for this meeting. | Say-on-Pay | Board | AGAINST | 1 | |
| FLUENCE ENERGY, INC. | March 12, 2026 | To approve the amendment and restatement of the Company's 2021 Incentive Award Plan. | Compensation | Board | ABSTAIN | 1 | |
| GENTHERM INCORPORATED | May 14, 2026 | Approval of the Amendment to the Gentherm Incorporated 2023 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| GILEAD SCIENCES, INC. | April 30, 2026 | To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| HALEON PLC | April 29, 2026 | GENERAL AUTHORITY TO DISAPPLY PRE-EMPTION RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| HCA HEALTHCARE, INC. | April 23, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. | Audit-related | Board | AGAINST | 1 | |
| HEALTHEQUITY, INC. | June 25, 2026 | To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. | Compensation | Board | ABSTAIN | 1 | |
| HILLTOP HOLDINGS INC. | July 24, 2025 | Non-binding advisory vote to approve executive compensation. | Say-on-Pay | Board | AGAINST | 1 | |
| HUBSPOT, INC. | June 15, 2026 | Approve an amendment to the Company's 2024 Stock Option and Incentive Plan; | Compensation | Board | AGAINST | 1 | |
| INFORMA PLC | June 18, 2026 | AUTHORISE ISSUE OF EQUITY WITHOUT PRE-EMPTIVE RIGHTS | Capital Structure | Board | ABSTAIN | 1 | |
| INGLES MARKETS, INCORPORATED | April 30, 2026 | COMPANY NOMINEE OPPOSED BY SUMMER ROAD: Rebekah Lowe | Director Elections | Board | WITHHOLD | 1 | |
| INSPIRE MEDICAL SYSTEMS, INC. | April 30, 2026 | Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. | Compensation | Board | ABSTAIN | 1 | |
| INTEL CORPORATION | May 13, 2026 | Approval of amendment and restatement of the 2006 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| INTERCONTINENTAL EXCHANGE, INC. | May 15, 2026 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. | Audit-related | Board | AGAINST | 1 | |
| INTERNATIONAL BUSINESS MACHINES CORP. | April 28, 2026 | Advisory Vote on Executive Compensation | Say-on-Pay | Board | AGAINST | 1 | |
| INTERNATIONAL BUSINESS MACHINES CORP. | April 28, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm | Audit-related | Board | AGAINST | 1 | |
| IONIS PHARMACEUTICALS, INC. | June 4, 2026 | To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares. | Compensation | Board | ABSTAIN | 1 | |
| JAMES HARDIE INDUSTRIES PLC | October 29, 2025 | To receive and consider the remuneration report for fiscal year 2025 | Say-on-Pay | Board | AGAINST | 1 | |
| KIMBERLY-CLARK CORPORATION | May 14, 2026 | Ratification of Auditor | Audit-related | Board | AGAINST | 1 | |
| KONINKLIJKE PHILIPS N.V. | May 8, 2026 | Authorization of the Board of Management to (i) issue shares or grant rights to acquire shares and (ii) restrict or exclude pre- emption rights: Proposal to authorize the Board of Management for a period of 18 months, effective May 8, 2026, as the body which is authorized, with the approval of the Supervisory Board, to issue shares or grant rights to acquire shares within the limits laid down in the Articles of Association | Capital Structure | Board | ABSTAIN | 1 | |
| LAMAR ADVERTISING COMPANY | May 14, 2026 | Approval of an amendment and restatement of the Company's 2019 Employee Stock Purchase Plan. | Capital Structure | Board | ABSTAIN | 1 |
← Previous Page 4 of 5 Next →
← Back to Gabelli 2025-2026 overview
Built October 18, 2026 from SEC Form N-PX filings.